Christophe Von Garnier

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


125 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | 2000 |
Physical activity and lung function association in a healthy community-dwelling European population.
Collaud S., Touilloux B., von Garnier C., Marques-Vidal P., Kraege V., 2024/04/08. BMC pulmonary medicine, 24 (1) p. 169. Peer-reviewed.
 
What makes asthma characterized by airway eosinophilia become severe?
Rothe T., Ubags N., von Garnier C., 2024/04. Respirology, 29 (4) pp. 280-282. Peer-reviewed.
 
Dépistage du cancer pulmonaire : vers l’implémentation d’un projet pilote en Suisse [Lung cancer screening : towards the implementation of a pilot project in Switzerland]
Bongard C., Rey Cobo J., Messe R., Noirez L., Lovis A., Krueger T., Peters S., Pozzessere C., Selby K., von Garnier C., 2023/11/15. Revue medicale suisse, 19 (850) pp. 2165-2171. Peer-reviewed.
 
Quels défis pour la pneumologie de demain?
Bergeron A., von Garnier C., 2023/11/15. Revue medicale suisse, 19 (850) pp. 2135-2136. Peer-reviewed.
Clinical characteristics governing treatment adjustment in COPD patients: results from the Swiss COPD cohort study.
Kleinsorge L., Pasha Z., Boesing M., Abu Hussein N., Bridevaux P.O., Chhajed P.N., Geiser T., Joos Zellweger L., Kohler M., Maier S. et al., 2023/11/04. Swiss medical weekly, 153 (11) p. 40114. Peer-reviewed.
Risk Factors for Recurrent Exacerbations in the General-Practitioner-Based Swiss Chronic Obstructive Pulmonary Disease (COPD) Cohort.
Abu Hussein N.S., Giezendanner S., Urwyler P., Bridevaux P.O., Chhajed P.N., Geiser T., Joos Zellweger L., Kohler M., Miedinger D., Pasha Z. et al., 2023/10/23. Journal of clinical medicine, 12 (20) p. 6695. Peer-reviewed.
Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort.
Mangold V., Boesing M., Berset C., Bridevaux P.O., Geiser T., Joos Zellweger L., Kohler M., Lüthi-Corridori G., Maier S., Miedinger D. et al., 2023/10/20. Journal of clinical medicine, 12 (20) p. 6636. Peer-reviewed.
 
Circulating calprotectin levels four months after severe and non-severe COVID-19.
Abu Hussein N., Machahua C., Ruchti S.C., Horn M.P., Piquilloud L., Prella M., Geiser T.K., von Garnier C., Funke-Chambour M., 2023/10/03. BMC infectious diseases, 23 (1) p. 650. Peer-reviewed.
 
BPCO : une maladie encore négligée [COPD : a still neglected condition]
Leuppi J.D., Bridevaux P.O., Charbonnier F., Clarenbach C.F., Duchna H.W., Fellrath J.M., Gianella P., Jochmann A., Kern L., Pavlov N. et al., 2023/09/06. Revue medicale suisse, 19 (840) pp. 1627-1633. Peer-reviewed.
Prevalence of small airway dysfunction in the Swiss PneumoLaus Cohort.
Touilloux B., Bongard C., Lechartier B., Truong M.K., Marques-Vidal P., Vollenweider P., Vaucher J., Casutt A., von Garnier C., 2023/09. ERJ open research, 9 (5) p. 00381. Peer-reviewed.
COPD – eine unterschätzte Erkrankung [COPD - An Underestimated Disease]
Leuppi J.D., Bridevaux P.O., Charbonnier F., Clarenbach C.F., Duchna H.W., Fellrath J.M., Gianella P., Jochmann A., Kern L., Pavlov N. et al., 2023/06. Praxis, 112 (7-8) pp. 403-412. Peer-reviewed.
 
Medical and Personal Characteristics Can Predict the Risk of Lung Metastasis.
Jamshidi E., Asgary A., Setareh S., Casutt A., Gonzalez M., Bianchi M.P., Lovis A., De Palma M., von Garnier C., Mansouri N., 2023/06. Clinical oncology, 35 (6) pp. e362-e375. Peer-reviewed.
Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis.
Gijs P.J., Daccord C., Bernasconi E., Brutsche M., Clarenbach C.F., Hostettler K., Guler S.A., Mercier L., Ubags N., Funke-Chambour M. et al., 2023/05. ERJ open research, 9 (3) pp. 00720-2022. Peer-reviewed.
 
Granulomatose avec polyangéite : quoi de neuf ? [Granulomatosis with polyangiitis: what's new?]
Ringwald M., Chevalley D., Bongard C., Kissling S., Rotman S., Von Garnier C., Ribi C., Comte D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 674-679. Peer-reviewed.
Long-Term Consequences of COVID-19: A 1-Year Analysis.
Bamps L., Armenti J.P., Bojan M., Grandbastien B., von Garnier C., Du Pasquier R., Desgranges F., Papadimitriou-Olivgeris M., Alberio L., Preisig M. et al., 2023/04/03. Journal of clinical medicine, 12 (7) p. 2673. Peer-reviewed.
 
Lung stereotactic radiation therapy: Intercomparison of irradiation devices in terms of outcome and predictive factors.
Le Reun E., Casutt A., Durham A., Bouchaab H., Romano E., Lovis A., Krueger T., Von Garnier C., Özsahin E.M., Kinj R., 2023/02. Cancer radiotherapie, 27 (1) pp. 31-41. Peer-reviewed.
Radiation Exposure to Low-Dose Computed Tomography for Lung Cancer Screening: Should We Be Concerned?
Pozzessere C., von Garnier C., Beigelman-Aubry C., 2023/01/24. Tomography, 9 (1) pp. 166-177. Peer-reviewed.
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry.
Jaun F., Tröster L.M., Giezendanne S., Bridevaux P.O., Charbonnier F., Clarenbach C., Gianella P., Jochmann A., Kern L., Miedinger D. et al., 2023. Respiration; international review of thoracic diseases, 102 (10) pp. 863-878. Peer-reviewed.
Home Use of Mechanical Insufflation/Exsufflation in Adult Patients in Western Switzerland.
Mitropoulou G., Heinzer R., Janssens J.P., von Garnier C., Prella M., 2023. Respiration; international review of thoracic diseases, 102 (5) pp. 341-350. Peer-reviewed.
Performance of microbiological tests for tuberculosis diagnostic according to the type of respiratory specimen: A 10-year retrospective study.
Boldi M.O., Denis-Lessard J., Neziri R., Brouillet R., von-Garnier C., Chavez V., Mazza-Stalder J., Jaton K., Greub G., Opota O., 2023. Frontiers in cellular and infection microbiology, 13 p. 1131241. Peer-reviewed.
Personalized predictions of adverse side effects of the COVID-19 vaccines.
Jamshidi E., Asgary A., Kharrazi A.Y., Tavakoli N., Zali A., Mehrazi M., Jamshidi M., Farrokhi B., Maher A., von Garnier C. et al., 2023/01. Heliyon, 9 (1) pp. e12753. Peer-reviewed.
 
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study.
Lenoir A., Christe A., Ebner L., Beigelman-Aubry C., Bridevaux P.O., Brutsche M., Clarenbach C., Erkosar B., Garzoni C., Geiser T. et al., 2023. Respiration; international review of thoracic diseases, 102 (2) pp. 120-133. Peer-reviewed.
The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly.
Rothe T., von Garnier C., Bridevaux P.O., Charbonnier F., Clarenbach C., Gianella P., Jochmann A., Kern L., Nikolay P., Steurer-Stey C. et al., 2023/01. Respiratory medicine, 206 p. 107067. Peer-reviewed.
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations.
Mitropoulou G., Koutsokera A., Csajka C., Blanchon S., Sauty A., Brunet J.F., von Garnier C., Resch G., Guery B., 2022/12/31. European respiratory review, 31 (166) p. 220121. Peer-reviewed.
 
Macrolides et pneumopathies chroniques [Macrolides antibiotics and chronic pulmonary disease]
Nater A., Von Garnier C., Mouraux S., 2022/11/23. Revue medicale suisse, 18 (805) pp. 2206-2212. Peer-reviewed.
 
Phagothérapie pour traiter les infections respiratoires [Phage therapy for respiratory infections]
Mitropoulou G., Gijs P.J., Koutsokera A., Sauty A., Blanchon S., Csajka C., Brunet J.F., Resch G., Guery B., Von Garnier C., 2022/11/16. Revue medicale suisse, 18 (804) pp. 2150-2156. Peer-reviewed.
Pneumopathies radiques - Pathophysiologie, classification, facteurs de risque et prise en charge en 2022 [Radiation-induced pneumonitis : pathophysiology, risk factors and work-up in 2022]
Bongard C., Campaner R.M., Bernard G., Lovis A., Von Garnier C., Kinj R., Casutt A., 2022/11/16. Revue medicale suisse, 18 (804) pp. 2134-2142. Peer-reviewed.
 
Unis pour être meilleurs.
Von Garnier C., Bergeron A., 2022/11/16. Revue medicale suisse, 18 (804) pp. 2131-2132. Peer-reviewed.
Frailty predicts outcomes in cystic fibrosis patients listed for lung transplantation.
Koutsokera A., Sykes J., Theou O., Rockwood K., Steinack C., Derkenne M.F., Benden C., Krueger T., Chaparro C., Aubert J.D. et al., 2022/11. The Journal of heart and lung transplantation, 41 (11) pp. 1617-1627. Peer-reviewed.
Nouveautés dans la prise en charge de l’asthme [Novelties in the Treatment of Asthma]
Leuppi J.D., Bridevaux P.O., Charbonnier F., Clarenbach C., Duchna H.W., Gianella P., Jochmann A., Kern L., Meyer F., Pavlov N. et al., 2022/06/22. Revue medicale suisse, 18 (787) pp. 1269-1274. Peer-reviewed.
New perspectives of biological therapy for severe asthma in adults and adolescents.
Chheang C., Guinand S., von Garnier C., Sartori C., 2022/05/23. Swiss medical weekly, 152 pp. w30176. Peer-reviewed.
Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation.
Trompette A., Pernot J., Perdijk O., Alqahtani RAA, Domingo J.S., Camacho-Muñoz D., Wong N.C., Kendall A.C., Wiederkehr A., Nicod L.P. et al., 2022/05. Mucosal immunology, 15 (5) pp. 908-926. Peer-reviewed.
The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program.
Jungblut L., von Garnier C., Puhan M., Tomonaga Y., Kaufmann C., Azzola A., Bürgi U., Bremerich J., Brutsche M., Christe A. et al., 2022/04/11. Swiss medical weekly, 152 (15-16) pp. w30154. Peer-reviewed.
 
Endobronchial Clip Device Insertion for Tracking Central Lesions.
Casutt A., Kinj R., Ozsahin E.M., von Garnier C., Gonzalez M., Lovis A., 2022/04/01. Journal of bronchology & interventional pulmonology, 29 (2) pp. e18-e20. Peer-reviewed.
Frailty assessment for COVID-19 follow-up: a prospective cohort study.
Müller I., Mancinetti M., Renner A., Bridevaux P.O., Brutsche M.H., Clarenbach C., Garzoni C., Lenoir A., Naccini B., Ott S. et al., 2022/04. BMJ open respiratory research, 9 (1) pp. e001227. Peer-reviewed.
Fiducial markers for stereotactic lung radiation therapy: review of the transthoracic, endovascular and endobronchial approaches.
Casutt A., Kinj R., Ozsahin E.M., von Garnier C., Lovis A., 2022/03/31. European respiratory review, 31 (163) p. 210149. Peer-reviewed.
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
Domizio J.D., Gulen M.F., Saidoune F., Thacker V.V., Yatim A., Sharma K., Nass T., Guenova E., Schaller M., Conrad C. et al., 2022/03. Nature, 603 (7899) pp. 145-151. Peer-reviewed.
Editorial: Neglected lung diseases in the COVID-19 era.
Yildirim F., Özkaya S., Erçen Diken Ö., von Garnier C., 2022. Frontiers in medicine, 9 p. 1016008. Peer-reviewed.
Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.
Palmieri F., Koutsokera A., Bernasconi E., Junier P., von Garnier C., Ubags N., 2022. Frontiers in medicine, 9 p. 832510. Peer-reviewed.
Adénomégalies médiastinohilaires - Approche clinique chez l’adulte immunocompétent hors contexte oncologique [Clinical approach to enlarged mediastinal and hilar lymph nodes other than the oncological causes]
Campaner R.M., Casutt A., Noirez L., Beigelman-Aubry C., Lovis A., Von Garnier C., 2021/11/17. Revue medicale suisse, 17 (759) pp. 1967-1974. Peer-reviewed.
Approche diagnostique et thérapeutique d’un asthme difficile [Diagnostic and therapeutic approach to difficult asthma]
Grandbastien M., Kolb M., Ribi C., Von Garnier C., 2021/11/17. Revue medicale suisse, 17 (759) pp. 1979-1983. Peer-reviewed.
La pneumologie en marche []
Soccal P.M., Von Garnier C., 2021/11/17. Revue medicale suisse, 17 (759) pp. 1959-1960. Peer-reviewed.
Séquelles respiratoires liées au Covid-19 : dépistage et prise en charge [Covid-19 respiratory sequelae : Screening and management]
Truong M.K., Mitropoulou G., Lenoir A., Beigelman-Aubry C., Piquilloud L., Prella M., Von Garnier C., 2021/11/17. Revue medicale suisse, 17 (759) pp. 1992-1999. Peer-reviewed.
 
Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature.
Mansouri N., Marjani M., Tabarsi P., von Garnier C., Mansouri D., 2021/11. Immunological investigations, 50 (8) pp. 884-890. Peer-reviewed.
Imaging in the aftermath of COVID-19: what to expect.
Ebner L., Funke-Chambour M., von Garnier C., Ferretti G., Ghaye B., Beigelman-Aubry C., 2021/06. European radiology, 31 (6) pp. 4390-4392. Peer-reviewed.
 
Endobronchial coil spring fiducial markers for CyberKnife® stereotactic body radiation therapy.
Casutt A., Noirez L., Bernasconi M., Koutsokera A., Beigelman-Aubry C., Kinj R., Ozsahin E.M., Durham A.D., von Garnier C., Lovis A., 2021/05. Respirology, 26 (5) pp. 469-476. Peer-reviewed.
 
A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation.
Das S., Bernasconi E., Koutsokera A., Wurlod D.A., Tripathi V., Bonilla-Rosso G., Aubert J.D., Derkenne M.F., Mercier L., Pattaroni C. et al., 2021/04/09. Nature communications, 12 (1) p. 2126. Peer-reviewed.
Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study.
Guler S.A., Ebner L., Aubry-Beigelman C., Bridevaux P.O., Brutsche M., Clarenbach C., Garzoni C., Geiser T.K., Lenoir A., Mancinetti M. et al., 2021/04. The European respiratory journal, 57 (4) p. 2003690. Peer-reviewed.
 
Neues in der Asthma-Grundversorgung [Novelties in the Treatment of Asthma]
Leuppi J.D., Bridevaux P.O., Charbonnier F., Clarenbach C., Duchna H.W., Gianella P., Jochmann A., Kern L., Meyer F., Pavlov N. et al., 2021. Praxis, 110 (16) pp. 967-974. Peer-reviewed.
Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID.
Funke-Chambour M., Bridevaux P.O., Clarenbach C.F., Soccal P.M., Nicod L.P., von Garnier C., Swiss COVID Lung Study Group and the Swiss Society of Pulmonology, 2021. Respiration; international review of thoracic diseases, 100 (8) pp. 826-841. Peer-reviewed.
Covid-19, what else ? []
Von Garnier C., Soccal P.M., 2020/11/18. Revue medicale suisse, 16 (715) pp. 2195-2196. Peer-reviewed.
Dépistage du cancer pulmonaire en Suisse : Qui ? Comment ? Quand ? [Lung cancer screening in Switzerland : Who ? How ? When ?]
Casutt A., Lovis A., Selby K., Noirez L., Peters S., Beigelman-Aubry C., Krueger T., Soccal P.M., Von Garnier C., 2020/11/18. Revue medicale suisse, 16 (715) pp. 2224-2226. Peer-reviewed.
Dépistage du cancer du poumon : que dire à nos patient·e·s en attendant un programme organisé ? [Lung cancer screening: what can we tell our patients while we await a screening program ?]
Selby K., Gubelmann R., Lovis A., Bulliard J.L., Beigelman-Aubry C., Casutt A., Peters S., Krueger T., Von Garnier C., Cornuz J., 2020/11/04. Revue medicale suisse, 16 (713) pp. 2086-2091. Peer-reviewed.
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.
Passaro A., Addeo A., Von Garnier C., Blackhall F., Planchard D., Felip E., Dziadziuszko R., de Marinis F., Reck M., Bouchaab H. et al., 2020/06. ESMO open, 5 (Suppl 3). Peer-reviewed.
Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography.
Rotzinger D.C., Beigelman-Aubry C., von Garnier C., Qanadli S.D., 2020/06. Thrombosis research, 190 pp. 58-59. Peer-reviewed.
Prise en charge de l’asthme et de la BPCO en situation de pandémie de COVID-19 [Asthma and COPD management during the COVID-19 pandemic]
Daccord C., Touilloux B., Von Garnier C., 2020/05/06. Revue medicale suisse, 16 (692) pp. 933-938. Peer-reviewed.
 
Multi-walled carbon nanotubes activate and shift polarization of pulmonary macrophages and dendritic cells in an in vivo model of chronic obstructive lung disease
Beyeler S., Steiner S., Wotzkow C., Tschanz S. A., Adhanom Sengal A., Wick P., Haenni B., Alves M. P., von Garnier C., Blank F., 2020/02. Nanotoxicology, 14 (1) pp. 77-96.
 
IL-17–high asthma with features of a psoriasis immunophenotype
Östling Jörgen, van Geest Marleen, Schofield James P.R., Jevnikar Zala, Wilson Susan, Ward Jonathan, Lutter Rene, Shaw Dominick E., Bakke Per S., Caruso Massimo et al., 2019/11. Journal of Allergy and Clinical Immunology, 144 (5) pp. 1198-1213.
 
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]
Leuppi J. D., Schmid-Grendelmeier P., Rothe T., von Garnier C., Simon H. U., Schuoler C., Pendl G., Soler M., 2019. Praxis (Bern 1994), 108 (7) pp. 469-476.
 
Acute effects of multi-walled carbon nanotubes on primary bronchial epithelial cells from COPD patients
Beyeler S., Chortarea S., Rothen-Rutishauser B., Petri-Fink A., Wick P., Tschanz S. A., von Garnier C., Blank F., 2018/09. Nanotoxicology, 12 (7) pp. 699-711.
 
Endobronchial coil therapy in severe emphysema: 6-month outcomes from a Swiss National Registry.
Fellrath J.M., Scherer T., Franzen D.P., Lovis A., von Garnier C., Plojoux J., Soccal P.M., 2018/08. Journal of thoracic disease, 10 (Suppl 23) pp. S2711-S2718. Peer-reviewed.
Microbial and host immune factors as drivers of COPD.
Mika M., Nita I., Morf L., Qi W., Beyeler S., Bernasconi E., Marsland B.J., Ott S.R., von Garnier C., Hilty M., 2018/07. ERJ open research, 4 (3) pp. 1-10. Peer-reviewed.
 
Pulmonary Fibrous Nodule with Ossifications May Indicate Vascular Ehlers-Danlos Syndrome with Missense Mutation in COL3A1.
Berezowska S., Christe A., Bartholdi D., Koch M., von Garnier C., 2018/03/01. American journal of respiratory and critical care medicine, 197 (5) pp. 661-662. Peer-reviewed.
 
Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP)
Dutau H., Breen D., Bugalho A., Dalar L., Daniels J., Dooms C., Eberhardt R., Ek L., Encheva M., Febvre M. et al., 2018. Respiration, 95 (1) pp. 44-54.
 
Lung responses in murine models of experimental asthma: Value of house dust mite over ovalbumin sensitization
Doras C., Petak F., Bayat S., Baudat A., Von Garnier C., Eigenmann P., Habre W., 2018/01. Respir Physiol Neurobiol, 247 pp. 43-51.
 
Sputum basophils and asthma diagnosis: dawn of a new era?
Fux M., von Garnier C., 2017/10. Allergy, 72 (10) pp. 1437-1439.
 
Virosome-bound antigen enhances DC-dependent specific CD4(+) T cell stimulation, inducing a Th1 and Treg profile in vitro
Blom R. A. M., Amacker M., Moser C., van Dijk R. M., Bonetti R., Seydoux E., Hall S. R. R., von Garnier C., Blank F., 2017/07. Nanomedicine, 13 (5) pp. 1725-1737.
 
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics.
Lefaudeux D., De Meulder B., Loza M.J., Peffer N., Rowe A., Baribaud F., Bansal A.T., Lutter R., Sousa A.R., Corfield J. et al., 2017/06. The Journal of allergy and clinical immunology, 139 (6) pp. 1797-1807. Peer-reviewed.
 
Identification and Characterization of a Dendritic Cell Precursor in Parenchymal Lung Tissue
von Garnier C., Blank F., Rothen-Rutishauser B., Goethert J. R., Holt P. G., Stumbles P. A., Strickland D. H., 2017/03. Am J Respir Cell Mol Biol, 56 (3) pp. 353-361.
 
Aerosol Delivery of Functionalized Gold Nanoparticles Target and Activate Dendritic Cells in a 3D Lung Cellular Model
Fytianos K., Chortarea S., Rodriguez-Lorenzo L., Blank F., von Garnier C., Petri-Fink A., Rothen-Rutishauser B., 2017. ACS Nano, 11 (1) pp. 375-383.
 
Interaction of biomedical nanoparticles with the pulmonary immune system
Blank F., Fytianos K., Seydoux E., Rodriguez-Lorenzo L., Petri-Fink A., von Garnier C., Rothen-Rutishauser B., 2017. J Nanobiotechnology, 15 (1) p. 6.
 
Pleural Biopsies: Just Freeze It?
Berezowska S., von Garnier C., 2017. Respiration; international review of thoracic diseases, 94 (1) pp. 16-17. Peer-reviewed.
 
Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4(+) T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen
Blom R. A. M., Amacker M., van Dijk R. M., Moser C., Stumbles P. A., Blank F., von Garnier C., 2017. Front Immunol, 8 p. 359.
 
Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.
Loza M.J., Djukanovic R., Chung K.F., Horowitz D., Ma K., Branigan P., Barnathan E.S., Susulic V.S., Silkoff P.E., Sterk P.J. et al., 2016/12/15. Respiratory research, 17 (1) p. 165.
 
A pathogenic role for the integrin CD103 in experimental allergic airways disease
Fear V. S., Lai S. P., Zosky G. R., Perks K. L., Gorman S., Blank F., von Garnier C., Stumbles P. A., Strickland D. H., 2016/11. Physiol Rep, 4 (21).
 
Pulmonary delivery of cationic gold nanoparticles boost antigen-specific CD4(+) T Cell Proliferation
Seydoux E., Rodriguez-Lorenzo L., Blom R. A., Stumbles P. A., Petri-Fink A., Rothen-Rutishauser B. M., Blank F., von Garnier C., 2016/10. Nanomedicine, 12 (7) pp. 1815-1826.
 
Current in vitro approaches to assess nanoparticle interactions with lung cells
Fytianos K., Drasler B., Blank F., von Garnier C., Seydoux E., Rodriguez-Lorenzo L., Petri-Fink A., Rothen-Rutishauser B., 2016/09. Nanomedicine (Lond), 11 (18) pp. 2457-69.
 
Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies.
Yadava K., Pattaroni C., Sichelstiel A.K., Trompette A., Gollwitzer E.S., Salami O., von Garnier C., Nicod L.P., Marsland B.J., 2016/05/01. American journal of respiratory and critical care medicine, 193 (9) pp. 975-987. Peer-reviewed.
 
A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and Virosomes
Blom R. A., Erni S. T., Krempaska K., Schaerer O., van Dijk R. M., Amacker M., Moser C., Hall S. R., von Garnier C., Blank F., 2016. PLoS One, 11 (9) pp. e0163539.
 
Tuberculosis and Migration: A Challenge for Medical Staff and Public Health
Griesshammer I., Srivastava D. S., von Garnier C., Blaser T. S., Exadaktylos A., Steib M., 2016. Case Rep Emerg Med, 2016 p. 8186036.
 
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Shaw D. E., Sousa A. R., Fowler S. J., Fleming L. J., Roberts G., Corfield J., Pandis I., Bansal A. T., Bel E. H., Auffray C. et al., 2015/11. Eur Respir J, 46 (5) pp. 1308-21.
 
Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial
Schuetz P., Leuppi J. D., Bingisser R., Bodmer M., Briel M., Drescher T., Duerring U., Henzen C., Leibbrandt Y., Maier S. et al., 2015/07. Eur J Endocrinol, 173 (1) pp. 19-27.
 
Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro
Fytianos K., Rodriguez-Lorenzo L., Clift M. J., Blank F., Vanhecke D., von Garnier C., Petri-Fink A., Rothen-Rutishauser B., 2015/04. Nanomedicine, 11 (3) pp. 633-44.
 
Early detection of lung cancer: a statement from an expert panel of the Swiss university hospitals on lung cancer screening.
Frauenfelder T., Puhan M.A., Lazor R., von Garnier C., Bremerich J., Niemann T., Christe A., Montet X., Gautschi O., Weder W. et al., 2014. Respiration; International Review of Thoracic Diseases, 87 (3) pp. 254-264.
 
Fluorescence-encoded gold nanoparticles: library design and modulation of cellular uptake into dendritic cells
Rodriguez-Lorenzo L., Fytianos K., Blank F., von Garnier C., Rothen-Rutishauser B., Petri-Fink A., 2014. Small, 10 (7) pp. 1341-50.
 
Persistent and compartmentalised disruption of dendritic cell subpopulations in the lung following influenza A virus infection
Strickland D. H., Fear V., Shenton S., Wikstrom M. E., Zosky G., Larcombe A. N., Holt P. G., Berry C., von Garnier C., Stumbles P. A., 2014. PLoS One, 9 (11) pp. e111520.
 
Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation
Seydoux E., Rothen-Rutishauser B., Nita I. M., Balog S., Gazdhar A., Stumbles P. A., Petri-Fink A., Blank F., von Garnier C., 2014. Int J Nanomedicine, 9 pp. 3885-902.
 
Microbial communities in the respiratory tract of patients with interstitial lung disease
Garzoni C., Brugger S. D., Qi W., Wasmer S., Cusini A., Dumont P., Gorgievski-Hrisoho M., Muhlemann K., von Garnier C., Hilty M., 2013/12. Thorax, 68 (12) pp. 1150-6.
 
SerpinB1 deficiency is not associated with increased susceptibility to pulmonary emphysema in mice
Cremona T. P., Tschanz S. A., von Garnier C., Benarafa C., 2013/12. Am J Physiol Lung Cell Mol Physiol, 305 (12) pp. L981-9.
 
Size-dependent uptake of particles by pulmonary antigen-presenting cell populations and trafficking to regional lymph nodes
Blank F., Stumbles P. A., Seydoux E., Holt P. G., Fink A., Rothen-Rutishauser B., Strickland D. H., von Garnier C., 2013/07. Am J Respir Cell Mol Biol, 49 (1) pp. 67-77.
 
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
Leuppi J. D., Schuetz P., Bingisser R., Bodmer M., Briel M., Drescher T., Duerring U., Henzen C., Leibbrandt Y., Maier S. et al., 2013. JAMA, 309 (21) pp. 2223-31.
 
Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients
Muhlethaler K., Bogli-Stuber K., Wasmer S., von Garnier C., Dumont P., Rauch A., Muhlemann K., Garzoni C., 2012/04. Eur Respir J, 39 (4) pp. 971-8.
 
Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients.
Engler K., Mühlemann K., Garzoni C., Pfahler H., Geiser T., von Garnier C., 2012. Swiss medical weekly, 142 pp. w13509. Peer-reviewed.
 
Update in clinical allergy and immunology.
von Gunten S., Marsland B.J., von Garnier C., Simon D., 2012. Allergy, 67 (12) pp. 1491-1500.
 
Opportunities and challenges of the pulmonary route for vaccination
Blank F., Stumbles P., von Garnier C., 2011/05. Expert Opin Drug Deliv, 8 (5) pp. 547-63.
 
[Smoking behaviour and willingness to stop smoking in patients admitted in an internal medicine ward]
Miedinger D., Drescher T., Nester N., Zeller A., von Garnier C., Leuppi J. D., 2011. Praxis (Bern 1994), 100 (9) pp. 525-30.
 
Biomedical nanoparticles modulate specific CD4(+) T cell stimulation by inhibition of antigen processing in dendritic cells
Blank F., Gerber P., Rothen-Rutishauser B., Sakulkhu U., Salaklang J., De Peyer K., Gehr P., Nicod L.P., Hofmann H., Geiser T. et al., 2011. Nanotoxicology, 5 (4) pp. 606-621. Peer-reviewed.
 
Comment on "Pre- and intra-operative mediastinal staging in non-small-cell lung cancer".
von Garnier C., Geiser T., 2011. Swiss medical weekly, 141 pp. w13289; author reply w13288. Peer-reviewed.
 
Endobronchial ultrasound in hilar and conventional TBNA-negative/inconclusive mediastinal lymphadenopathy
Chhajed P. N., Odermatt R., von Garnier C., Chaudhari P., Leuppi J. D., Stolz D., Tamm M., 2011. J Cancer Res Ther, 7 (2) pp. 148-51.
 
Macrophages and dendritic cells express tight junction proteins and exchange particles in an in vitro model of the human airway wall
Blank F., Wehrli M., Lehmann A., Baum O., Gehr P., von Garnier C., Rothen-Rutishauser B. M., 2011. Immunobiology, 216 (1-2) pp. 86-95.
 
Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4+ T cell proliferation during the induction of inhalation tolerance
Fear V. S., Burchell J. T., Lai S. P., Wikstrom M. E., Blank F., von Garnier C., Turner D. J., Sly P. D., Holt P. G., Strickland D. S. et al., 2011. J Immunol, 187 (9) pp. 4561-70.
 
[Preventive relapse treatment for tobacco cessation - is it worthwhile?]
von Garnier C., 2010/08. Ther Umsch, 67 (8) pp. 431-3.
 
Smoking cessation counselling: impact of chart stickers and resident training.
von Garnier C., Meyer M., Leuppi J., Battegay E., Zeller A., 2010/03/20. Swiss medical weekly, 140 (11-12) pp. 175-180. Peer-reviewed.
 
Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions
Spirig R., Djafarzadeh S., Regueira T., Shaw S. G., von Garnier C., Takala J., Jakob S. M., Rieben R., Lepper P. M., 2010. PLoS One, 5 (6) pp. e0010983.
 
Fatal cerebral air embolism following uneventful flexible bronchoscopy
Azzola A., von Garnier C., Chhajed P. N., Schirp U., Tamm M., 2010. Respiration, 80 (6) pp. 569-72.
 
Identification and isolation of rodent respiratory tract dendritic cells
Stumbles P. A., Strickland D. H., Wikstrom M. E., Thomas J. A., von Garnier C., Holt P. G., 2010. Methods Mol Biol, 595 pp. 249-63.
 
Airway hyperresponsiveness is associated with activated CD4+ T cells in the airways
Zosky G. R., Larcombe A. N., White O. J., Burchell J. T., von Garnier C., Holt P. G., Turner D. J., Wikstrom M. E., Sly P. D., Stumbles P. A., 2009/08. Am J Physiol Lung Cell Mol Physiol, 297 (2) pp. L373-9.
Immunology taught by lung dendritic cells.
von Garnier C., Nicod L.P., 2009/04/04. Swiss medical weekly, 139 (13-14) pp. 186-192. Peer-reviewed.
 
A rare cause of acute respiratory failure and elevated eosinophils in broncho-alveolar lavage fluid.
Knudsen L., Gugger M., Dumont P., Nicod L., von Garnier C., 2009. Respiration, 77 (2) pp. 224-8. Peer-reviewed.
 
Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease
Mauermann N., Burian J., von Garnier C., Dirnhofer S., Germano D., Schuett C., Tamm M., Bingisser R., Eriksson U., Hunziker L., 2008. Am J Respir Crit Care Med, 178 (4) pp. 379-88.
 
Pica and refractory iron deficiency anaemia: a case report
von Garnier C., Stunitz H., Decker M., Battegay E., Zeller A., 2008. J Med Case Rep, 2 p. 324.
 
Role of dendritic cells in the lung: in vitro models, animal models and human studies
Blank Fabian, Von Garnier Christophe, Obregon Carolina, Rothen-Rutishauser Barbara, Gehr Peter, Nicod Laurent, 2008. Expert Review of Respiratory Medicine, 2 (2) pp. 215-233. Peer-reviewed.
 
Smoking cessation advice: Swiss physicians lack training
von Garnier C., Kochuparackal S., Miedinger D., Leuppi J. D., Tamm M., Battegay E., Zeller A., 2008. Cancer Detect Prev, 32 (3) pp. 209-14.
 
Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa
von Garnier C., Wikstrom M. E., Zosky G., Turner D. J., Sly P. D., Smith M., Thomas J. A., Judd S. R., Strickland D. H., Holt P. G. et al., 2007. J Immunol, 179 (9) pp. 5748-59.
 
Comment on "Local CD11c+ MHC Class II- precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process"
von Garnier C., Strickland D., Stumbles P., 2007. J Immunol, 178 (5) pp. 2609; author reply 2609-10.
 
Downregulation of IgE antibody and allergic responses in the lung by epidermal biolistic microparticle delivery
Kendall M., Mitchell T. J., Costigan G., Armitage M., Lenzo J. C., Thomas J. A., von Garnier C., Zosky G. R., Turner D. J., Stumbles P. A. et al., 2006/02. J Allergy Clin Immunol, 117 (2) pp. 275-82.
 
[A 81-year-old patient with physiotherapy-resistant upper limb tenderness]
von Garnier C., Bar D., Daikeler T., Rafeiner P., 2006. Praxis (Bern 1994), 95 (45) pp. 1768-70.
 
[Resistant anemia in resistant patients]
Bar D., Keller D. I., von Garnier C., Kummer H., 2006. Praxis (Bern 1994), 95 (46) pp. 1807-8.
 
Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen
Wikstrom M. E., Batanero E., Smith M., Thomas J. A., von Garnier C., Holt P. G., Stumbles P. A., 2006. J Immunol, 177 (2) pp. 913-24.
 
Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract
von Garnier C., Filgueira L., Wikstrom M., Smith M., Thomas J. A., Strickland D. H., Holt P. G., Stumbles P. A., 2005. J Immunol, 175 (3) pp. 1609-18.
 
Dalteparin reduced venous thromboembolic events without increased bleeding in acutely ill medical patients
von Garnier C., Ryan G., 2005. ACP J Club, 143 (1) pp. A11; discussion A11.
 
The pattern of methacholine responsiveness in mice is dependent on antigen challenge dose
Zosky G. R., von Garnier C., Stumbles P. A., Holt P. G., Sly P. D., Turner D. J., 2004. Respir Res, 5 p. 15.
 
In vivo kinetics of the immunoglobulin E response to allergen: bystander effect of coimmunization and relationship with anaphylaxis
Von Garnier C., Astori M., Kettner A., Dufour N., Corradin G., Spertini F., 2002/03. Clinical and Experimental Allergy, 32 (3) pp. 401-10.
 
Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice
Astori M., von Garnier C., Kettner A., Dufour N., Corradin G., Spertini F., 2000/09. Journal of Immunology, 165 (6) pp. 3497-505.
 
Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis
von Garnier C., Astori M., Kettner A., Dufour N., Heusser C., Corradin G., Spertini F., 2000/06. European Journal of Immunology, 30 (6) pp. 1638-45.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University